After the storm: Teva beats estimates

Third quarter EPS of $1.27 on revenue of $5.1 billion compares with a consensus estimate of $1.26 on revenue of $5 billion.

After the turmoil of the ouster of its CEO, Jeremy Levin, yesterday, today Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) presents its third quarter results, reporting non-GAAP earnings per share of $1.27 on revenue of $5.1 billion. The consensus analysts' estimate was earnings per share of $1.26 on revenue of $5 billion.

In a conference call yesterday, acting CEO Eyal Desheh confirmed the company's guidance for the year as a whole: earnings per share of $4.95-5.05 on revenue of $19.7-20.3 billion.

On a GAAP basis, earnings per share in the third quarter of 2013 were $0.84

Sales of generic drugs were flat in the quarter, at $2.5 billion, of which $1.1 billion were in the US (a rise of 6%). In Europe, generic sales fell 1% to $812 million. Despite growing competition, overall Copaxone sales rose 1% to $1.05 billion, with sales in the US climbing 3% to $798 million in the quarter.

“Teva’s leadership and board of directors remain committed to executing on our strategy and diligently implementing changes which we believe will ensure the growth of our business,” Desheh said today, adding, “During the quarter we had six successful generic product launches in the US alone, and are pleased that our generic business continues to benefit from a long-term, sustainable and profitable growth. We are also satisfied with the performance of our Global Specialty Medicines business and OTC joint venture."

Cash flow from operations during the quarter was $444 million, compared with $1.1 billion in the third quarter of 2012, a decrease of 58%. Free cash flow, which excludes net capital expenditures and dividends, was a negative $34 million this quarter, compared with positive free cash flow of $577 million in the third quarter of 2012. The company said that the decrease in cash flow was mainly due to the payments made in connection with litigation settlements. Excluding the effect of these settlements, cash flow from operations and free cash flow were a solid $1.3 billion and $856 million, respectively, in the quarter. Cash and marketable securities at the end of September amounted to $1.4 billion.

Teva's board of directors declared a cash dividend for the third quarter of 2013 of NIS 1.15 per share (approximately $0.326).

Published by Globes [online], Israel business news - www.globes-online.com - on October 31, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

Itamar Ben-Gvir  credit: Noam Moskowitz, Knesset Spokesperson's Office Otzma Yehudit rejoins government

Itamar Ben-Gvir's party left the government in January in protest against the ceasefire in Gaza. The resumption of fighting has paved its way back.

Wiz founders Yinon Costica, Assaf Rappaport, Ami Luttwak, Roy Reznik credit: Avishag Shaar Yishuv Israel's biggest ever exit: Google buying Wiz for $32b

Google has confirmed that an agreement has been signed for an all-cash deal. Wiz will remain an independent company under Google.

Bezhalel Machlis  credit: Assaf Shilo/Israel Sun Elbit Systems CEO: Our potential in Europe is huge

Bezhalel Machlis was speaking at an investor conference after the company released 2024 results showing revenue up 14.3%.

Gaza Strip, March 17 2025  credit: Reuters/Anadolu IDF resumes assault on Hamas

Extensive aerial attacks were carried out against targets in the Gaza Strip overnight.

Wiz founders Yinon Costica, Assaf Rappaport, Ami Luttwak, Roy Reznik credit: Avishag Shaar Yishuv Google renews attempt to buy Wiz - report

According to "The Wall Street Journal", Google parent company Alphabet is negotiating to buy the Israeli cloud computing security company for $30 billion.

Orit Strook  credit: Marc Israel Sellem/The Jerusalem Post Finance C'ttee approves NIS 300m coalition funds distribution

The money will mainly go to Religious Zionist party minister Orit Strook's Ministry of Settlements and National Missions.

Dangoor Academy  credit: British Embassy in Tel Aviv British Embassy showcases Israeli healthcare startups

The nine startups participated in the Dangoor HealthTech Academy, a program that connects Israeli startups with the UK healthcare system.

NextVision Stabilized Systems  credit: Shlomi Yosef/Tali Bogdanovsky Next Vision shareholders make NIS 230m exit

A British hedge fund has bought a 2.5% stake in the stabilized cameras company.

Energean CEO Mathios Rigas at the Israel Business Conference   credit: Shlomi Yosef Energean's $1b gas fields sale at risk

The sale of the energy company's asset portfolio in Egypt, Italy and Croatia may fall through because of the buyer's difficulties with the Italian regulator.

Kela Technologies founders Jason Manne, Hamutal Meridor, Alon Dror and Omer Bar Ilan  credit:  Yosef Haim Alterman Defense tech co Kela raises $39m

In response to the events of October 7, Kela has developed a platform for rapid integration of commercial technologies into military systems.

Benjamin Netanyahu  credit: ‎Alex Kolomoisky, Yediot Aharonot Firing the Shin Bet chief: The hurdles

Prime Minister Benjamin Netanyahu says he has "lost trust" in Shin Bet head Ronen Bar. Will this be enough to overcome legal challenges to his dismissal?

Emiliano Calemzuk  credit: PR CEO and "investor group" buying out Reshet 13

CEO Emiliano Calemzuk and the other investors will hold 74% of the television channel, while Len Blavatnik’s Access Industries and WBD will remain with 26%.

Inflation  credit: Tali Bogdanovsky Unexpectedly low February CPI reading cuts inflation

While inflation in Israel in the 12 months to the end of February 2025 is lower than forecast, housing prices continue to rise.

Yitzhak Tshuva credit: Gidon Levy and Tali Bogdanovsky Competition Authority allows Delek takeover of Isracard

The Competition Authority is considered the easier of the two regulatory hurdles that the deal must overcome, the other being the Supervisor of Banks.

David Amsalem  credit  Noam Moskowitz, Knesset Spokesperson's Office Rafael to pay state NIS 444m dividend

The minister in charge of the Government Companies Authority, David Amsalem, has approved the payment by the defense company.

Barak MX air defense system  credit: IAI IAI profit jumps 55%

Israel Aerospace Industries posted a net profit of $493 million for 2024, and ended the year with an all-time high orders backlog of $25 billion.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018